MEP of the week

Lobby organisation

Orion Corporation

Company · Health & pharma · HQ: Finland · Transparency Register entry

As of 7 November 2026, Orion Corporation appears in 8 declared MEP meetings (5 different MEPs), most often with Renew Europe.

8
declared meetings
with current MEPs
5
MEPs met
€25k/yr
declared lobbying spend
self-reported to the register
0.3
lobbyists
full time equivalent

In their own words

“Orion Pharma is a globally operating Finnish pharmaceutical company. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of our pharmaceutical R&D are oncology and pain.​ Orion Pharma builds well-being by bringing to markets drugs and therapies from which patients get help for their illnesses.”

Read the rest of the statementShow less of the statement

“Orion Pharma has around 4000 employees around the world. Our products are sold in over one hundred countries. We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 8 declared meetings, by the meeting MEP's political group.

Renew Europe562%
European Conservatives & Reformists112%
European People's Party112%
Greens/EFA112%

Meetings by year

Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (4 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.

2023
1
2024
2
2025
1
2026
4

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Katri Kulmuni
4 meetings · Renew
Ville Niinistö
1 meeting · Greens/EFA
Anna-Maja Henriksson
1 meeting · Renew
Sebastian Tynkkynen
1 meeting · ECR
Sirpa Pietikäinen
1 meeting · EPP

The 8 most recent declared meetings

DateMEPSubject
22 Sep 2026Katri KulmuniBiotech Acts
11 May 2026Katri KulmuniUWWTD-direktiivi
8 May 2026Sebastian TynkkynenYhdys­kun­ta­jä­te­ve­si­di­rek­tiivi
6 Mar 2026Katri KulmuniBiotech I
6 Feb 2025Sirpa PietikäinenCritical Medicines
20 Nov 2024Anna-Maja HenrikssonTrade policy
16 Oct 2024Katri KulmuniAjankohtaiset EU-lakihankkeet
23 Oct 2023Ville NiinistöPharmaceutical legislation

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.